NDC 0002-4454-01 - Zyprexa
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0002-4454
- Requested NDC
- 0002-4454-01
- Package NDCs from labels
- 0002-4454-01, 0002-4454-85
- Manufacturer
- Eli Lilly and Company
- Effective date
- 2025-11-18
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Zyprexa - Eli Lilly and Company | Eli Lilly and Company | 2025-11-18 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0002-4454-01 | ZYPREXA Zydis | 1 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 1 | 67 | |
| 0002-4454-01 | ZYPREXA Zydis | 1 in 1 DOSE PACK | TABLET, ORALLY DISINTEGRATING | 1 | 67 | |
| 0002-4454-85 | ZYPREXA Zydis | 30 in 1 CARTON | TABLET, ORALLY DISINTEGRATING | 30 | 67 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 0002-4454 | ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ] | 66 | Legacy NDC, 3 package rows | 20250110_d5051fbc-846b-4946-82df-341fb1216341.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0002-4454-01 | EA - Each | 0002-4454 | 7e221558-7584-4b8b-b359-bbce11fe7e20 | 1 | 2012-07-24 |
| 0002-4454-85 | EA - Each | 0002-4454 | 9879037d-1deb-4639-8596-ead22339987d | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Olanzapine | OLANZAPINE | Macleods Pharmaceuticals Limited | df43938a-3469-40eb-8166-f0a2fd29d6d8 | 2026-03-05 | Boxed warning, Warnings, Adverse reactions | 312076 351108 351107 314155 N7U69T4SZR |
| Calamine | CALAMINE, PRAMOXINE HCL | Amazon.com Services LLC | aceb0b10-8c90-4a06-8c47-cd1a2b4676a3 | 2026-03-03 | Warnings, Adverse reactions | 1K09F3G675 |
| OLANZAPINE | OLANZAPINE | Torrent Pharmaceuticals Limited | 2cb1bebe-0ced-46d8-bf21-c28a9acc4a15 | 2026-03-02 | Boxed warning, Warnings, Adverse reactions | 200034 312076 351108 283639 312079 312077 314154 351107 312078 314155 N7U69T4SZR |
| Calamine | FERRIC OXIDE RED | Old East Main Co. | c38c77fd-abbf-4c87-a9c0-a0e21ed3f97d | 2026-03-02 | Warnings, Adverse reactions | 1K09F3G675 |
| Olanzapine | OLANZAPINE | American Regent, Inc. | e9ac2bd3-dbff-4b1a-952f-da3909c6e4ee | 2026-03-01 | Boxed warning, Warnings, Adverse reactions | 485968 N7U69T4SZR |
| Refresh Optive Mega-3 PF | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 | Allergan, Inc. | 326cb5d6-c784-404f-9a13-6d69262dda6e | 2026-03-01 | Warnings | 6OZP39ZG8H |
| Olanzapine | OLANZAPINE | Teva Pharmaceuticals USA, Inc. | dd0b2525-4e2f-44fc-9302-0ae4ebb1e135 | 2026-02-27 | Boxed warning, Warnings, Adverse reactions | 312076 351108 351107 314155 N7U69T4SZR |
| Calamine | FERRIC OXIDE RED | Chain Drug Marketing Association | 86ff4875-9007-4b7b-8f46-16cbd475d4bb | 2026-02-27 | Warnings, Adverse reactions | 1K09F3G675 |
| Calamine | CALAMINE, PRAMOXINE HCL | Chain Drug Marketing Association | 6c848b98-f01c-40f2-a9aa-2af76cb370c8 | 2026-02-27 | Warnings, Adverse reactions | 1K09F3G675 |
| Levico Prunus | LEVICO PRUNUS | Uriel Pharmacy Inc. | 63db9374-8ee2-48cf-8799-454c95869808 | 2026-02-27 | Warnings | 1K09F3G675 |
| TIBENA EVERY DAY REAL SUN BLOCK | TITANIUM DIOXIDE, ZINC OXIDE | KONAD CO LTD | 211c9930-4f91-cf8f-e063-6394a90a97b3 | 2026-02-26 | Warnings | 15FIX9V2JP |
| CLE DE PEAU BEAUTE RADIANT FLUID FOUNDATION MATTE M B10 | TITANIUM DIOXIDE | Shiseido Americas Corporation | 54f8210f-4934-4ada-89c3-aa89e7a09260 | 2026-02-26 | Warnings | 15FIX9V2JP |
| Olanzapine | OLANZAPINE | Sandoz Inc | c44a96cc-817d-4eb5-a13a-00977f76e666 | 2026-02-26 | Boxed warning, Warnings, Adverse reactions | 485968 N7U69T4SZR |
| SHISEIDO UV PROTECTIVE COMPACT (REFILL) FAIR IVORY | OCTINOXATE, OCTOCRYLENE, AND TITANIUM DIOXIDE | SHISEIDO AMERICAS CORPORATION | c05cef12-a6a7-4682-9357-6d77f4ca3267 | 2026-02-25 | Warnings | 15FIX9V2JP |
| cle de peau BEAUTE RADIANT FOUNDATION N M I10 | OCTINOXATE AND TITANIUM DIOXIDE | Shiseido Americas Corporation | 3be1fe06-bd3b-4078-bee9-d3caf8d068ff | 2026-02-25 | Warnings | 15FIX9V2JP |
| cle de peau BEAUTE THE FOUNDATION N M O20 | OCTINOXATE AND TITANIUM DIOXIDE | Shiseido Americas Corporation | 9507f6d1-c11c-428d-8d95-b436f27ba26a | 2026-02-24 | Warnings | 15FIX9V2JP |
| Calamine | FERRIC OXIDE RED | Family Dollar Stores, Inc | 1a03331e-3676-451c-be22-9a547e8ae6e2 | 2026-02-24 | Warnings, Adverse reactions | 1K09F3G675 |
| Perfect Mineral Sunscreen | TITANIUM DIOXIDE, ZINC OXIDE | SKIN PERFECT MEDICAL | 4b93538a-3b3e-90f7-e063-6294a90ab898 | 2026-02-24 | Warnings | 15FIX9V2JP |
| ANTI-AGING TINTED SUNSCREEN | TITANIUM DIOXIDE, ZINC OXIDE | LASER GIRL SKINCARE, LLC | 4b93cd22-1289-29bc-e063-6294a90ab781 | 2026-02-24 | Warnings | 15FIX9V2JP |
| ANTI-AGING TINTED SUNSCREEN | TITANIUM DIOXIDE, ZINC OXIDE | LASER GIRL SKINCARE, LLC | 4b943d72-dcde-e2e4-e063-6294a90ab7c4 | 2026-02-24 | Warnings | 15FIX9V2JP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.